loureirin b has been researched along with Cicatrix, Hypertrophic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, X; Fan, L; He, T; Hu, D; Liu, J; Shi, J; Su, L; Tang, C; Tao, K; Wang, Y | 1 |
Bai, X; Fan, L; Gao, J; Han, S; He, T; Hu, D; Li, Y; Su, L; Yang, L | 1 |
2 other study(ies) available for loureirin b and Cicatrix, Hypertrophic
Article | Year |
---|---|
Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Topics: Adolescent; Adult; Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cicatrix, Hypertrophic; Disease Models, Animal; Down-Regulation; Extracellular Matrix; Female; Fibroblasts; Humans; Male; Matrix Metalloproteinases; Myofibroblasts; Rabbits; Resins, Plant; RNA, Messenger; Smad Proteins; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Young Adult | 2015 |
Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-β1-ERK/JNK Pathway.
Topics: Adolescent; Adult; Cells, Cultured; Cicatrix, Hypertrophic; Collagen Type I; Fibronectins; Gene Expression Regulation; Humans; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Resins, Plant; Tissue Culture Techniques; Transforming Growth Factor beta1; Young Adult | 2015 |